Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial for Atrial fibrillation

Trial Profile

Phase II trial for Atrial fibrillation

Phase of Trial: Phase II

Latest Information Update: 14 Nov 2018

At a glance

  • Drugs AP-30663 (Primary)
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Nov 2018 New trial record
    • 05 Nov 2018 According to Acesion Pharma media release, study is expected to start in second quarter of 2019
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top